首页> 外文期刊>Carcinogenesis >A population-based study of dna repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype
【24h】

A population-based study of dna repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype

机译:基于人群的与非黑素瘤皮肤癌相关的dna修复基因变异的研究,作为易发癌表型的标志物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

For unknown reasons, non-melanoma skin cancer (NMSC) is associated with increased risk of other malignancies. Focusing solely on DNA repair or DNA repair-related genes, this study tested the hypothesis that DNA repair gene variants contribute to the increased cancer risk associated with a personal history of NMSC. From the parent CLUE II cohort study, established in 1989 in Washington County, MD, the study consisted of a cancer-free control group (n 5 2296) compared with three mutually exclusive groups of cancer cases ascertained through 2007: (i) Other (non-NMSC) cancer only (n 5 2349); (ii) NMSC only (n 5 694) and (iii) NMSC plus other cancer (n 5 577). The frequency of minor alleles in 759 DNA repair gene single nucleotide polymorphisms (SNPs) was compared in these four groups. Comparing those with both NMSC and other cancer versus those with no cancer, 10 SNPs had allelic trend P-values 0.01. The two top-ranked SNPs were both within the thymine DNA glycosylase gene (TDG). One was a non-synonymous coding SNP (rs2888805) [per allele odds ratio (OR) 1.40, 95% confidence interval (CI) 1.16-1.70; P-value 5 0.0006] and the other was an intronic SNP in high linkage disequilibrium with rs2888805 (rs4135150). None of the associations had a P-value 6.6310 -5, the threshold for statistical significance after correcting for multiple comparisons. The results pinpoint DNA repair genes most likely to contribute to the NMSC cancer-prone phenotype. A promising lead is genetic variants in TDG, important not only in base excision repair but also in regulating the epigenome and gene expression, which may contribute to the NMSC-associated increase in overall cancer risk.
机译:出于未知原因,非黑色素瘤皮肤癌(NMSC)与其他恶性肿瘤风险增加相关。这项研究仅关注于DNA修复或与DNA修复相关的基因,检验了DNA修复基因变体导致与NMSC个人病史相关的癌症风险增加的假设。这项父项CLUE II队列研究于1989年在马里兰州华盛顿县成立,该研究由无癌对照组(n 5 2296)与2007年确定的三个相互排斥的癌症病例组组成:(i)其他(仅非NMSC)癌症(n 5 2349); (ii)仅NMSC(n 5694)和(iii)NMSC加其他癌症(n 5577)。比较这四组中759个DNA修复基因单核苷酸多态性(SNP)中次要等位基因的频率。将同时患有NMSC和其他癌症的患者与未患有癌症的患者进行比较,有10个SNP具有等位基因趋势P值<0.01。两个排名最高的SNP都在胸腺嘧啶DNA糖基化酶基因(TDG)中。一种是非同义编码SNP(rs2888805)[每个等位基因比值比(OR)1.40,95%置信区间(CI)1.16-1.70; P值5 [0.0006],另一个是与rs2888805(rs4135150)高连锁不平衡的内含子SNP。没有一个关联的P值<6.6310 -5,这是校正多个比较后的统计显着性阈值。结果确定了最有可能促成NMSC癌症易感表型的DNA修复基因。 TDG的遗传变异是有前途的先导,不仅对碱基切除修复有重要意义,而且在调节表观基因组和基因表达方面也很重要,这可能会导致与NMSC相关的总体癌症风险增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号